Larramendi C H, Chiner E, Calpe J L, Puigcerver M T
Seccions d'allèrgia i pneumologia, Hospital de la Marina Baixa, La Vila Joiosa (Alacant), Spain.
Allergol Immunopathol (Madr). 1997 Mar-Apr;25(2):85-90.
Certain diuretics such as furosemide, when inhaled, have been found to be useful in preventing Exercise-Induced Asthma (EIA).
To assess the possible preventive effect of inhaled amiloride in EIA.
A double blind, randomized, cross-over study comparing the effect of inhaled amiloride, inhaled furosemide and placebo in EIA.
Sixteen asthmatic patients (8 males and 8 females) with an average age of 21 years (range 9-31) who presented a FEV1 decrease of over 15% in a previous free-running exercise test.
Solutions were inhaled with a Hudson nebulizer connected to an oxygen source in different days before exercise testing. A Vitalograph Compact (Ohmeda, England) spirometer was used and FEV1 was obtained at baseline, three minutes after solution inhalation, immediately after exercise and then every 5 min. until 20 minutes post-exercise. The changes in FEV1 percentages (FEV1%) and the mean FEV1 decreases expressed as percentages for each solution were compared.
Inhaled furosemide diminished the fall in the FEV1 at every time after exercise. The maximum decrease in mean FEV1 was at 5 minutes post-exercise and was 11 +/- 7% with furosemide, 24 +/- 14% (p < 0.01) with amiloride and 19 +/- 12% (p < 0.05) with placebo. Amiloride administration resulted in a slight but significative increase in the FEV1 fall (p < 0.01 when compared with placebo).
Amiloride is not useful to protect EIA whereas Furosemide does it. These differences results may be related to the differents mechanisms of action of the two diuretics.
某些利尿剂,如呋塞米,吸入时已被发现可有效预防运动诱发哮喘(EIA)。
评估吸入阿米洛利对运动诱发哮喘的可能预防作用。
一项双盲、随机、交叉研究,比较吸入阿米洛利、吸入呋塞米和安慰剂对运动诱发哮喘的影响。
16名哮喘患者(8名男性和8名女性),平均年龄21岁(9 - 31岁),在之前的自由运动试验中第一秒用力呼气量(FEV1)下降超过15%。
在运动测试前不同日期,用连接氧气源的哈德逊雾化器吸入溶液。使用肺活量计(英国奥美达公司生产的Vitalograph Compact),在基线、吸入溶液三分钟后、运动后立即以及运动后每5分钟直至20分钟时获取FEV1。比较每种溶液的FEV1百分比变化(FEV1%)和以百分比表示的平均FEV1下降情况。
吸入呋塞米可减少运动后各时间点的FEV1下降。平均FEV1的最大下降出现在运动后5分钟,呋塞米组为11±7%,阿米洛利组为24±14%(p < 0.01),安慰剂组为19±12%(p < 0.05)。使用阿米洛利导致FEV1下降略有但显著增加(与安慰剂相比p < 0.01)。
阿米洛利对预防运动诱发哮喘无效,而呋塞米有效。这些差异结果可能与两种利尿剂不同的作用机制有关。